Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Keratoconus
Interventions
DEVICE

Corneal Collagen Crosslinking

Keratoconic corneas that show significant progression as specified in the inclusion criteria section will receive one single treatment with CXL if randomized to the treatment arm. A treatment protocol based on 30 minutes dropping with riboflavin/dextran solution and 10 minutes UV-illumination treatment will be used.

Trial Locations (1)

43180

Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal

All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

Sahlgrenska University Hospital

OTHER